SCHEMBL21744628

SCHEMBL21744628

c1cc(-c2ccc3cnccc3c2)c2nc[nH]c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 2/20 0.56
PIK3CD O00329 1/20 0.55
PIK3CB P42338 1/20 0.55
PIK3CG P48736 1/20 0.55
ABL1 P00519 1/20 0.54
BRD4 O60885 1/20 0.47
PRKCI P41743 1/20 0.44
HASPIN Q8TF76 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
GRM4 Q14833 1/20 0.40
AKT1 P31749 7/20 0.40
PRKCG P05129 2/20 0.40
CDK1 P06493 2/20 0.40
PRKACA P17612 2/20 0.40
PRKACG P22612 2/20 0.40
PRKACB P22694 2/20 0.40
MAPK1 P28482 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27143869 0.77 QPCT (0.51) TDO2ABL1BRD4CYP1A2CYP3A4
SCHEMBL29960424 0.77 QPCT (0.51) TDO2ABL1BRD4CYP1A2CYP3A4
SCHEMBL903206 0.73 BRD4 (0.52) ABL1BRD4HASPINMAPK1QPCT
SCHEMBL29208983 0.73 BRD4 (0.56) ABL1BRD4QPCTQPCTL
SCHEMBL31501287 0.72 BRD4 (0.49) TDO2ABL1BRD4CYP3A4CYP2D6
SCHEMBL20878376 0.72 BRD4 (0.56) ABL1BRD4
SCHEMBL903194 0.71 CYP17A1 (0.50) TDO2BRD4CYP1A2
SCHEMBL27151824 0.71 PARP1 (0.42) PIK3CDABL1BRD4CYP1A2CYP3A4
SCHEMBL900109 0.71 CYP17A1 (0.48) ABL1BRD4PRKACAPIM1QPCT
SCHEMBL29477064 0.71 DPP4 (0.57) ABL1BRD4CYP3A4AKT3CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 TDO2 4308/4885PIK3CD 519/4885PIK3CB 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.